Akinsanya Karen — SEC Form 4 filings
SEC reporting owner CIK 1797672. 8 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-05 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 20,295 shares, $463,650 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 8,378 shares @ $25.11 ($210,391) in Schrodinger, Inc., filed 2025-04-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Schrodinger, Inc. (SDGR) | See Remarks | 5 | — | 5 legs · 20,295 sh · $463,650 | 11 |
| Nautilus Biotechnology, Inc. (NAUT) | Director | 3 | — | — | 3 |
Form 4 filings — Akinsanya Karen
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-22 | 4 | Nautilus Biotechnology, Inc. (NAUT) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Schrodinger, Inc. (SDGR) | Sale (S): 1,366 @ $12.90 | EDGAR |
| 2026-03-03 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 24,250 @ $0 · Grant/award (A): 6,077 @ $0 · Grant/award (A): 27,576 @ $0 · Sale (S): 2,206 @ $11.99 · Grant/award (A): 48,500 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Nautilus Biotechnology, Inc. (NAUT) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-04-15 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 13,378 @ $3.22 · Option exercise (M): 3,345 @ $2.92 · Sale (S): 8,378 @ $25.11 · Sale (S): 5,000 @ $25.11 · Sale (S): 3,345 @ $25 · Option exercise (M): 13,378 (derivative) @ $0 · +1 more | EDGAR |
| 2025-03-04 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 15,625 @ $0 · Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Nautilus Biotechnology, Inc. (NAUT) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1797672 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →